ema semaglutide EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported European Medicines Agency to investigate

However, coverage for the CV indication varies by plansome MA plans have added Wegovy for cardiovascular risk reduction to their formularies while others have not

Epidemiology of chronic kidney disease: an update 2022

However, as gallbladder disease is not an issue with sodium-glucose co-transporter-2 (SGLT-2) inhibitors (with similar weight loss) (89), and gallbladder events also occurred in GLP-1RA-treated patients well after weight reduction (90), other mechanisms are possibly in play

Using it for this condition can lead to serious health issues, so its essential to use the right medication for the right diagnosis